Vaccinations

Report from federal advisory board discussions of J&J vaccine

Wed, 2021-04-14 22:33 — mike kraft

CDC vaccine advisers review Johnson & Johnson shot after reports of rare blood clots Federal health officials had recommended Tuesday that states pause use of the vaccine while agencies review six U.S. cases of a rare and severe type of brain blood clot among the more than 7 million people who received the shot. Lena H. Sun, Carolyn Y. Johnson Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Report from federal advisory board discussions of J&J vaccine
Log in or register to post comments

OPINION: The new vaccine threat is fear itself

Wed, 2021-04-14 16:42 — mike kraft

The new vaccine threat is fear itself The Johnson & Johnson pause is the latest example of how we've struggled to keep COVID risks in perspective. Sam Baker Axios

The FDA’s decision to pause the use of Johnson & Johnson's coronavirus vaccine has set off a chain reaction of fear — about the safety of the vaccine, and about whether the FDA is overreacting — that's causing unnecessary drama just as the vaccine effort is finally picking up speed.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about OPINION: The new vaccine threat is fear itself
Log in or register to post comments

Overview: Europeans assessing J&J vaccines, plus international briefs ,

Wed, 2021-04-14 16:25 — mike kraft

The Latest: European agency expects J&J recommendation soon LONDON -- The European Medicines Agency is assessing the rare blood clots reported in the U.S. after receiving the Johnson & Johnson COVID-19 vaccine, and a recommendation for European countries... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview: Europeans assessing J&J vaccines, plus international briefs ,
Log in or register to post comments

Countries to maintain vaccination drives amid concern of side effects

Wed, 2021-04-14 15:38 — mike kraft

Covid-19 live updates: World struggles to maintain vaccination drives amid mounting reports of side effects To date, more than 45 percent of the eligible U.S. population has received at least one vaccine dose though the number of new cases continued to trend upward at an average of 11 percent over the past week. At least 562,000 people have died. Erin Cunningham Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Countries to maintain vaccination drives amid concern of side effects
Log in or register to post comments

Pfizer speeds up its vaccine delivery after J&J pause

Wed, 2021-04-14 15:28 — mike kraft

Pfizer pushes to speed up its vaccine delivery after J&J pause Pfizer's CEO said Tuesday that the company has ramped up its vaccine production to deliver doses more quickly following a pause in distribution of the Johnson & Johnson vaccine. John Bowden TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer speeds up its vaccine delivery after J&J pause
Log in or register to post comments

Commentary: Perspectives on the J&J vaccine

Wed, 2021-04-14 02:49 — mike kraft

Three Different Futures for the Johnson & Johnson Vaccine A pause is just that—a pause—in which health officials can reevaluate the data at hand. Katherine J. Wu The Atlantic

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Commentary: Perspectives on the J&J vaccine
Log in or register to post comments

How the coronavirus variants work, younger persons increasingly affected

Wed, 2021-04-14 02:12 — mike kraft

More young people are getting hospitalized as a 'stickier,' more infectious coronavirus strain becomes dominant What used to be a mysterious new variant first detected in the UK is now the leading coronavirus strain in the US. And unlike the original novel coronavirus, B.1.1.7 is hitting young people particularly hard. Holly Yan, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about How the coronavirus variants work, younger persons increasingly affected
Log in or register to post comments

Background, history and observations on the development of various vaccines.

Wed, 2021-04-14 01:46 — mike kraft

Vaccine development for emerging infectious diseases Examination of the vaccine strategies and technical platforms used for the COVID-19 pandemic in the context of those used for previous emerging and reemerging infectious diseases and pandemics can offer critical lessons to prepare for future public health emergencies. Nature Medicine

Examination of the vaccine strategies and technical platforms used for the COVID-19 pandemic in the context of those used for previous emerging and reemerging infectious diseases and pandemics may offer some mutually beneficial lessons.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Background, history and observations on the development of various vaccines.
Log in or register to post comments

Discussion of 'Breakthrough' COVID Cases Among People Already Vaccinated

Wed, 2021-04-14 01:27 — mike kraft

Ginger Eatman thought she was safe after getting her second COVID-19 vaccination in February. But she kept wearing her mask, using hand sanitizer and wiping down the carts at the grocery store anyway. A few weeks later, she noticed a scratchy throat.

"By Wednesday morning, St. Patrick's Day, I was sick. I had congestion — a lot of congestion — and some coughing," says Eatman, 73, of Dallas, Ga.

Her doctor thought her symptoms might be allergies. But Eatman started feeling sicker. And then she suddenly lost her sense of smell. ...

So Eatman got tested for the coronavirus. It came back positive. ...

Eatman isn't alone in this experience. It's a long-recognized phenomenon called "vaccine breakthrough."

Country / Region Tags:

General Topic Tags: